Showing all 2 results

An endogenous neuropeptide that sits at the apex of reproductive endocrine control, with a substantial and growing human research literature.
$70.00
A melanocortin-4 receptor agonist approved in the United States for hypoactive sexual desire disorder in premenopausal women, making it one of the few compounds here with full trial evidence.
$85.00